Skip to Content

BMS 300 mg 3622 (Atazanavir Sulfate 300 mg)

Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Atazanavir Sulfate 300 mg. It is supplied by Greenstone LLC.

Atazanavir is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 300 mg 3622

Atazanavir sulfate 300 mg BMS 300 mg 3622
Atazanavir sulfate 300 mg BMS 300 mg 3622
Atazanavir sulfate 300 mg BMS 300 mg 3622

Atazanavir Sulfate

Imprint
BMS 300 mg 3622
Strength
300 mg
Color
Red / Blue
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Greenstone LLC
National Drug Code (NDC)
59762-0410
Inactive Ingredients
lactose monohydrate, magnesium stearate, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "BMS 300 mg 3622"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.